ArticleJournal of translational medicine2025

Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach.

Punchita Rujirachaivej et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.